Literature DB >> 20832494

Effect of influenza vaccination on hospitalizations in persons aged 50 years and older.

Roger Baxter1, G Thomas Ray, Bruce H Fireman.   

Abstract

OBJECTIVE: To estimate influenza vaccine effectiveness (VE) in preventing hospitalizations in persons over 50 years of age.
DESIGN: We performed a retrospective, population based study, using a "difference-in-differences" approach to determine the association between hospitalization and prior vaccination. We examined this association when influenza was not circulating and compared it to the association found when influenza was circulating. VE was estimated from the difference in the association between hospitalization and prior vaccination, inside vs. outside influenza seasons.
SETTING: Kaiser Permanente in Northern California. PATIENTS: Health plan members aged 50 years and older during the September 1997 to August 2008 study period, when there were about 68,000 pneumonia hospitalizations in 10 million person-years.
RESULTS: Vaccination was associated with lower risk of hospitalization for pneumonia and influenza, even before flu season, presumably due to unmeasured confounders. When influenza arrived the hospitalization-vaccination association strengthened, yielding an adjusted VE estimate of 12.4% (95% CI: 1.6-22.0) in persons aged 50-64, and 8.5% (95% CI: 3.3-13.5) in those aged 65 years and older. There was no significant effect on hospitalizations for ischemic heart disease (IHD), congestive heart failure (CHF), cerebrovascular disease (CVD), or trauma.
CONCLUSIONS: Influenza vaccination has a modest but significant effect on prevention of hospitalization for pneumonia and influenza in persons 50 years of age and older.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20832494     DOI: 10.1016/j.vaccine.2010.08.088

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  30 in total

1.  Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population.

Authors:  Adrian J Reber; Tatiana Chirkova; Jin Hyang Kim; Weiping Cao; Renata Biber; David K Shay; Suryaprakash Sambhara
Journal:  Aging Dis       Date:  2011-09-30       Impact factor: 6.745

2.  Impact of Statins on Influenza Vaccine Effectiveness Against Medically Attended Acute Respiratory Illness.

Authors:  Saad B Omer; Varun K Phadke; Robert A Bednarczyk; Allison T Chamberlain; Jennifer L Brosseau; Walter A Orenstein
Journal:  J Infect Dis       Date:  2015-10-28       Impact factor: 5.226

3.  Risk of confirmed Guillain-Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009-2010.

Authors:  Sharon K Greene; Melisa Rett; Eric S Weintraub; Lingling Li; Ruihua Yin; Anthony A Amato; Doreen T Ho; Sarah I Sheikh; Bruce H Fireman; Matthew F Daley; Edward A Belongia; Steven J Jacobsen; Roger Baxter; Tracy A Lieu; Martin Kulldorff; Claudia Vellozzi; Grace M Lee
Journal:  Am J Epidemiol       Date:  2012-05-11       Impact factor: 4.897

4.  The effectiveness of seasonal trivalent inactivated influenza vaccine in preventing laboratory confirmed influenza hospitalisations in Auckland, New Zealand in 2012.

Authors:  Nikki Turner; Nevil Pierse; Ange Bissielo; Q Sue Huang; Michael G Baker; Marc-Alain Widdowson; Heath Kelly
Journal:  Vaccine       Date:  2014-04-24       Impact factor: 3.641

5.  Controlling Time-Dependent Confounding by Health Status and Frailty: Restriction Versus Statistical Adjustment.

Authors:  Leah J McGrath; Alan R Ellis; M Alan Brookhart
Journal:  Am J Epidemiol       Date:  2015-04-12       Impact factor: 4.897

6.  Why We Should Not Be Indifferent to Specification Choices for Difference-in-Differences.

Authors:  Andrew M Ryan; James F Burgess; Justin B Dimick
Journal:  Health Serv Res       Date:  2014-12-11       Impact factor: 3.402

Review 7.  Effects of influenza immunization on pneumonia in the elderly.

Authors:  Jung Yeon Heo; Joon Young Song; Ji Yun Noh; Min Joo Choi; Jin Gu Yoon; Saem Na Lee; Hee Jin Cheong; Woo Joo Kim
Journal:  Hum Vaccin Immunother       Date:  2017-12-19       Impact factor: 3.452

8.  High-dose influenza vaccine use among patients receiving hemodialysis in the United States, 2010-2013.

Authors:  Leah J McGrath; J Bradley Layton; Whitney S Krueger; Abhijit V Kshirsagar; Anne M Butler
Journal:  Vaccine       Date:  2018-09-06       Impact factor: 3.641

9.  Influenza vaccine effectiveness assessment through sentinel virological data in three post-pandemic seasons.

Authors:  Núria Torner; Ana Martínez; Luca Basile; M Angeles Marcos; Andrés Antón; M Mar Mosquera; Ricard Isanta; Carmen Cabezas; Mireia Jané; Angela Domínguez; The Pidirac Sentinel Surveillance Program Of Catalonia
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

Review 10.  Recommended immunization schedules for adults: Clinical practice guidelines by the Escmid Vaccine Study Group (EVASG), European Geriatric Medicine Society (EUGMS) and the World Association for Infectious Diseases and Immunological Disorders (WAidid).

Authors:  Susanna Esposito; Paolo Bonanni; Stefania Maggi; Litjan Tan; Filippo Ansaldi; Pier Luigi Lopalco; Ron Dagan; Jean-Pierre Michel; Pierre van Damme; Jacques Gaillat; Roman Prymula; Timo Vesikari; Cristina Mussini; Uwe Frank; Albert Osterhaus; Lucia Pastore Celentano; Marta Rossi; Valentina Guercio; Gaetan Gavazzi
Journal:  Hum Vaccin Immunother       Date:  2016-05-02       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.